Study S001755

Efficacy of Cardiometabolic Risk Factor Control Through Metabolic Surgery on Management and Severity of Atrial Fibrillation: METSAFE Randomized Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07027969
Acronym: METSAFE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 100
Start: 2026-11-01
Primary completion: 2029-12-31
Lead sponsor: Ali Aminian
Conditions: Atrial Fibrillation; Obesity and Obesity-related Medical Conditions
Interventions: PROCEDURE:Roux-en-Y Gastric Bypass or Sleeve Gastrectomy; DRUG:Anti-Obesity Medication (AOM) treatment
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Relative change in total duration of being in atrial fibrillation (AF) [First 52 weeks of the study]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.